Entrada Therapeutics Reports First Quarter 2022 Financial Results

Go back to Entrada Therapeutics Reports First Quarter 2022 Financial Results
(NASDAQ: TRDA) Delayed: 7.17 +0.10 (1.41%)
Previous Close $7.07    52 Week High
Open $7.07    52 Week Low
Day High $7.24    P/E N/A 
Day Low $6.96    EPS
Volume 10,734